2026-07-12 21:26:47
Latest Post
LTM Limited Commences FY27 with Robust Trajectory as Q1 Net Profit Climbs 17% Year-on-Year to ₹14,686 Million
Gowra Leasing & Finance Q1 FY27 Net Profit Surges 123% Year-on-Year to ₹288.32 Lakh
Avenue Supermarts Unveils Q1 FY27 Performance: Net Profit Climbs to ₹860.44 Crore Amid Strong Operational Scaling
Avantel Limited Net Profit Climbs 67% Year-on-Year to ₹539.46 Lakh in Q1 FY27; Sequentially Up 13%
Just Dial Net Profit Climbs 4.1% Year-on-Year to ₹1,662.2 Million; Sequentially Surges 66%
Stock Report
Arunjyoti Bio Ventures Posts ₹61.24 Lakhs Net Profit in Q1 FY27; Sequentially Bounces Back from Losses
Posted On : 2026-07-12 11:01:39( TIMEZONE : IST )
Arunjyoti Bio Ventures Limited has announced its un-audited financial results for the first quarter of the fiscal year 2026-27 (Q1 FY27) ended June 30, 2026. The Hyderabad-based company successfully arrested its sequential downward trend, steering its bottom-line back into profitability from deep operational losses incurred in the previous quarter.
Income Performance and Revenue Traction
For the quarter ended June 30, 2026, Arunjyoti Bio Ventures recorded a revenue from operations of ₹820.00 lakhs (~₹8.20 crore). This represents a 13.30% sequential growth over the ₹723.73 lakhs reported in the immediate preceding quarter ended March 31, 2026 (Q4 FY26). However, compared to the corresponding period of the previous fiscal year (Q1 FY26), operational revenues witnessed a mild decline of 5.88% from ₹871.24 lakhs.
Coupled with an other income of ₹2.06 lakhs, the company's total income for the opening quarter of the fiscal year reached ₹822.06 lakhs, up from ₹731.92 lakhs sequentially but down slightly from ₹872.45 lakhs year-on-year.
Expenditure Optimization & Turnaround
The key driver behind the company's financial turnaround was a substantial curtailment of total operating expenses, which fell sharply to ₹740.22 lakhs from a high of ₹1,088.45 lakhs in Q4 FY26.
A specific look at the cost-containment across segments includes:
Employee Costs: Personnel expenses dropped significantly to ₹208.51 lakhs, from ₹342.55 lakhs sequentially and ₹260.24 lakhs year-on-year.
Other Expenses: General administrative and operational overheads were slashed almost by half sequentially, coming in at ₹313.28 lakhs compared to the ₹619.20 lakhs logged in the previous quarter.
Finance & Asset Depreciation: Financial charges stood at ₹44.08 lakhs, while depreciation and asset amortization expenses were recorded at ₹84.35 lakhs.
Owing to these cost optimizations and the absence of any further exceptional items, the company bounced back to report a Profit Before Tax (PBT) of ₹81.84 lakhs, a dramatic recovery from the pre-tax loss of ₹630.19 lakhs registered in the preceding quarter.
Profitability and Earnings Per Share
After factoring in a total tax outgo of ₹20.60 lakhs-comprising a current tax provision of ₹12.44 lakhs and a deferred tax charge of ₹8.16 lakhs-Arunjyoti Bio Ventures concluded the period with a Net Profit after tax of ₹61.24 lakhs. This bottom-line performance reverses a massive net loss of ₹540.09 lakhs reported in Q4 FY26, though it traces below the ₹204.54 lakhs achieved during the highly profitable year-ago opening quarter.
With zero other comprehensive income changes recorded, the total comprehensive income closely tracked the net profit at ₹61.24 lakhs. Against a stable paid-up equity share capital base of ₹1,863.81 lakhs (consisting of shares with a face value of ₹1 each), basic and diluted Earnings Per Share (EPS) normalized back into the positive territory at ₹0.03 per share, recovering from a negative EPS of ₹(0.29) in the preceding quarter.
